LLY |
Eli Lilly and Company |
824.51B |
5.39% |
|
|
|
|
|
869.58 |
-4.73% |
35.92% |
31.78% |
---|
PFE |
Pfizer Inc. |
151.49B |
5.28% |
|
|
|
|
|
26.73 |
1.87% |
28.68% |
60.61% |
---|
ABBV |
AbbVie Inc. |
378.30B |
5.22% |
|
|
|
|
|
214.29 |
1.68% |
22.93% |
36.26% |
---|
MRK |
Merck & Co., Inc. |
239.09B |
5.12% |
|
|
|
|
|
94.65 |
0.69% |
28.61% |
71.81% |
---|
BMY |
Bristol-Myers Squibb Company |
123.97B |
5.09% |
|
|
|
|
|
61.09 |
1.51% |
27.71% |
39.65% |
---|
ABT |
Abbott Laboratories |
237.84B |
5.05% |
|
|
|
|
|
137.14 |
1.53% |
21.98% |
41.86% |
---|
JNJ |
Johnson & Johnson |
401.33B |
4.83% |
|
|
|
|
|
166.69 |
0.52% |
18.95% |
45.69% |
---|
AMGN |
Amgen Inc. |
174.52B |
4.64% |
|
|
|
|
|
324.86 |
2.22% |
23.91% |
12.81% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
1.78B |
3.22% |
|
|
|
|
|
46.47 |
6.66% |
72.63% |
39.44% |
---|
GILD |
Gilead Sciences, Inc. |
146.22B |
2.95% |
|
|
|
|
|
117.41 |
1.18% |
26.32% |
39.54% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.79B |
2.92% |
|
|
|
|
|
32.07 |
0.79% |
43.71% |
32.91% |
---|
LQDA |
Liquidia Corporation |
1.25B |
2.91% |
|
|
|
|
|
14.82 |
-0.27% |
66.08% |
25.12% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
8.43B |
2.84% |
|
|
|
|
|
138.81 |
1.73% |
31.17% |
30.69% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
1.93B |
2.79% |
|
|
|
|
|
33.67 |
-0.12% |
54.28% |
39.32% |
---|
UTHR |
United Therapeutics Corporation |
14.19B |
2.77% |
|
|
|
|
|
315.91 |
2.67% |
35.09% |
97.61% |
---|
BIIB |
Biogen Inc. |
22.01B |
2.70% |
|
|
|
|
|
150.38 |
2.04% |
33.98% |
49.73% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
76.06B |
2.69% |
|
|
|
|
|
707.51 |
1.30% |
37.40% |
68.50% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.61B |
2.69% |
|
|
|
|
|
18.09 |
-4.49% |
77.53% |
7.66% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
910.25M |
2.68% |
|
|
|
|
|
28.91 |
-2.99% |
55.89% |
38.01% |
---|
VTRS |
Viatris Inc. |
11.52B |
2.65% |
|
|
|
|
|
9.65 |
1.47% |
30.87% |
72.32% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
4.11B |
2.64% |
|
|
|
|
|
8.90 |
1.60% |
67.35% |
19.75% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.20B |
2.63% |
|
|
|
|
|
7.54 |
2.72% |
132.65% |
68.31% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
1.32B |
2.63% |
|
|
|
|
|
60.62 |
-0.70% |
50.20% |
43.73% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.41B |
2.62% |
|
|
|
|
|
89.02 |
2.22% |
28.23% |
60.56% |
---|
INVA |
Innoviva, Inc. |
1.11B |
2.59% |
|
|
|
|
|
17.64 |
0.28% |
52.77% |
43.80% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.21B |
2.56% |
|
|
|
|
|
114.83 |
-1.01% |
51.23% |
63.51% |
---|
PRGO |
Perrigo Company plc |
3.79B |
2.55% |
|
|
|
|
|
27.76 |
-3.21% |
43.05% |
28.30% |
---|
CORT |
Corcept Therapeutics Incorporated |
5.84B |
2.52% |
|
|
|
|
|
55.40 |
2.03% |
65.42% |
54.78% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
1.37B |
2.40% |
|
|
|
|
|
28.81 |
1.73% |
55.34% |
46.18% |
---|
GERN |
Geron Corporation |
1.10B |
2.31% |
|
|
|
|
|
1.7300 |
0.58% |
92.88% |
24.61% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.14% |
|
|
|
|
|
|
|
|
|
---|